Prediction of pneumococcal conjugate vaccine effectiveness against invasive pneumococcal disease using opsonophagocytic activity and antibody concentrations determined by enzyme-linked immunosorbent assay with 22F adsorption.

Prediction of pneumococcal conjugate vaccine effectiveness against invasive pneumococcal disease using opsonophagocytic activity and antibody concentrations determined by enzyme-linked immunosorbent assay with 22F adsorption.

Item
http://www.wikidata.org/entity/Q39657425
Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine.Immunogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with DTPa vaccine in Japanese children: A randomized, controlled study.Changes in serotype distribution and antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Korea, after optional use of the 7-valent conjugate vaccine.Reduction of Streptococcus pneumoniae Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody.Low opsonic activity to the infecting serotype in pediatric patients with invasive pneumococcal disease.Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trialThe history of pneumococcal conjugate vaccine development: dose selection.Complex immune correlates of protection in HIV-1 vaccine efficacy trials.A Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection.Memory B-Cell Pools Predict the Immune Response to Pneumococcal Conjugate Vaccine in Immunocompromised Children.Development and Qualification of an Opsonophagocytic Killing Assay To Assess Immunogenicity of a Bioconjugated Escherichia coli Vaccine.Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences.
P2860

Prediction of pneumococcal conjugate vaccine effectiveness against invasive pneumococcal disease using opsonophagocytic activity and antibody concentrations determined by enzyme-linked immunosorbent assay with 22F adsorption.

Item
http://www.wikidata.org/entity/Q39657425
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Prediction of pneumococcal con ...... ent assay with 22F adsorption.
@en
Prediction of pneumococcal con ...... ent assay with 22F adsorption.
@nl
type
label
Prediction of pneumococcal con ...... ent assay with 22F adsorption.
@en
Prediction of pneumococcal con ...... ent assay with 22F adsorption.
@nl
prefLabel
Prediction of pneumococcal con ...... ent assay with 22F adsorption.
@en
Prediction of pneumococcal con ...... ent assay with 22F adsorption.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Prediction of pneumococcal con ...... bent assay with 22F adsorption
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932